{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:02:37Z","timestamp":1790794957922,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,19]]},"DOI":"10.7759\/cureus.47319","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T14:41:57Z","timestamp":1697726517000},"source":"Crossref","is-referenced-by-count":1,"title":["Disparities in Outcomes of Hospitalizations Due to Multiple Myeloma: A Nationwide Comparison"],"prefix":"10.7759","author":[{"given":"Sushmita","family":"Khadka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swetha","family":"Balaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Japjeet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanshree","family":"Solanki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariia","family":"Kasianchyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humayra","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishani","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Qasim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maheshkumar","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Maiyani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharmeshkumar V","family":"Moradiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darshan","family":"Lal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achint A","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manidhar","family":"Lekkala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-141723","article-title":"Disparities in outcomes of hospitalizations due to multiple myeloma: a nationwide comparison","volume":"136","author":"Bhesania S","year":"2020","unstructured":"Bhesania S, Anand S, Dabria T, et al.. Disparities in outcomes of hospitalizations due to multiple myeloma: a nationwide comparison. Blood. 2020, 136:5. 10.1182\/blood-2020-141723","journal-title":"Blood"},{"key":"ref2","unstructured":"Cancer stat facts. myeloma. (2021). Accessed: September 13, 2021: https:\/\/seer.cancer.gov\/statfacts\/html\/mulmy.html."},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.36.15_suppl.e20015","article-title":"Trends of hospitalization for multiple myeloma patients: insights from the national inpatient sample database","volume":"36","author":"Vakiti A","year":"2018","unstructured":"Vakiti A, Patel B, Jonnalagadda A, Moustafa MA, Stingo F, Mewawala P, Shenoy AG. Trends of hospitalization for multiple myeloma patients: insights from the national inpatient sample database. J Clin Oncol. 2018, 36:e20015-e20015.","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2005.00532.x","article-title":"Multiple myeloma in elderly patients: prognostic factors and outcome","volume":"75","author":"Anagnostopoulos A","year":"2005","unstructured":"Anagnostopoulos A, Gika D, Symeonidis A, et al.. Multiple myeloma in elderly patients: prognostic factors and outcome. Eur J Haematol. 2005, 75:370-5. 10.1111\/j.1600-0609.2005.00532.x","journal-title":"Eur J Haematol"},{"key":"ref5","unstructured":"Hospitalization burden of patients with multiple myeloma. (2021). Accessed. September, 22, 2021: https:\/\/www.cancertherapyadvisor.com\/home\/news\/conference-coverage\/american-society-of-hematology-ash\/ash-2020\/ash-20...."},{"key":"ref6","unstructured":"Understanding multiple myeloma. (2021). Accessed. September 13, 2021: https:\/\/themmrf.org\/multiple-myeloma\/prognosis\/understanding-survival-statistics\/.."},{"key":"ref7","article-title":"The relative importance of factors predicting outcome for myeloma patients at different ages: results from 3894 patients in the Myeloma XI trial","volume":"34","author":"Pawlyn C","year":"2019","unstructured":"Pawlyn C, Cairns D, Kaiser M, et al.. The relative importance of factors predicting outcome for myeloma patients at different ages: results from 3894 patients in the Myeloma XI trial. Leukemia. 2019, 34:604-12.","journal-title":"Leukemia"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.63","article-title":"Evolutionary biology of high-risk multiple myeloma","volume":"17","author":"Pawlyn C","year":"2017","unstructured":"Pawlyn C, Morgan GJ. Evolutionary biology of high-risk multiple myeloma. Nat Rev Cancer. 2017, 17:543-56. 10.1038\/nrc.2017.63","journal-title":"Nat Rev Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0141-0","article-title":"Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting","volume":"8","author":"Richardson PG","year":"2018","unstructured":"Richardson PG, San Miguel JF, Moreau P, et al.. Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting. Blood Cancer J. 2018, 8:109. 10.1038\/s41408-018-0141-0","journal-title":"Blood Cancer J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196596","article-title":"Real life management of patients hospitalized with multiple myeloma in France","volume":"13","author":"Dumontet C","year":"2018","unstructured":"Dumontet C, Couray-Targe S, Teisseire M, Karlin L, Maucort-Boulch D. Real life management of patients hospitalized with multiple myeloma in France. PLoS One. 2018, 13:e0196596. 10.1371\/journal.pone.0196596","journal-title":"PLoS One"},{"key":"ref11","unstructured":"Healthcare Cost and Utilization Project (HCUP). (2020). Accessed. May 7, 2020: https:\/\/www.ahrq.gov\/data\/hcup\/index.html."},{"key":"ref12","unstructured":"Trend weights for HCUP NIS data. (2020). Accessed. March 31, 2020: https:\/\/www.hcup-us.ahrq.gov\/db\/nation\/nis\/trendwghts.jsp."},{"key":"ref13","unstructured":"NIS description of data elements. (2020). Accessed. March 31, 2020: https:\/\/www.hcup-us.ahrq.gov\/db\/nation\/nis\/nisdde.jsp.."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4137\/ccrpm.s544","article-title":"Use of the all patient refined-diagnosis related group (APR-DRG) risk of mortality score as a severity adjustor in the medical ICU","volume":"2","author":"Baram D","year":"2008","unstructured":"Baram D, Daroowalla F, Garcia R, et al.. Use of the all patient refined-diagnosis related group (APR-DRG) risk of mortality score as a severity adjustor in the medical ICU. Clin Med Circ Respirat Pulm Med. 2008, 2:19-25. 10.4137\/ccrpm.s544","journal-title":"Clin Med Circ Respirat Pulm Med"},{"key":"ref15","unstructured":"Elixhauser comorbidity software, version 3.7. (2021). Accessed. May 22, 2021: https:\/\/www.hcup-us.ahrq.gov\/toolssoftware\/comorbidity\/comorbidity.jsp#overview."},{"key":"ref16","unstructured":"HCUP methods series. (2021). Accessed. May 22, 2021: https:\/\/www.hcup-us.ahrq.gov\/reports\/methods\/methods.jsp."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2009.0426","article-title":"Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinic","volume":"85","author":"Turesson I","year":"2010","unstructured":"Turesson I, Velez R, Kristinsson SY, Landgren O. Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinic. Mayo Clin Proc. 2010, 85:225-30. 10.4065\/mcp.2009.0426","journal-title":"Mayo Clin Proc"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2016002493","article-title":"Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States","volume":"1","author":"Costa LJ","year":"2017","unstructured":"Costa LJ, Brill IK, Omel J, Godby K, Kumar SK, Brown EE. Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States. Blood Adv. 2017, 1:282-7. 10.1182\/bloodadvances.2016002493","journal-title":"Blood Adv"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.380","article-title":"Trends in overall survival and costs of multiple myeloma, 2000-2014","volume":"31","author":"Fonseca R","year":"2017","unstructured":"Fonseca R, Abouzaid S, Bonafede M, Cai Q, Parikh K, Cosler L, Richardson P. Trends in overall survival and costs of multiple myeloma, 2000-2014. Leukemia. 2017, 31:1915-21. 10.1038\/leu.2016.380","journal-title":"Leukemia"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13083","article-title":"Rapidly changing myeloma epidemiology in the general population: increased incidence, older patients, and longer survival","author":"Turesson I","year":"2018","unstructured":"Turesson I, Bjorkholm M, Blimark CH, Kristinsson S, Velez R, Landgren O. Rapidly changing myeloma epidemiology in the general population: increased incidence, older patients, and longer survival. Eur J Haematol. 2018, 13083. 10.1111\/ejh.13083","journal-title":"Eur J Haematol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2018.01.015","article-title":"Trends of incidence, mortality, and survival of multiple myeloma in Switzerland between 1994 and 2013","volume":"53","author":"Andres M","year":"2018","unstructured":"Andres M, Feller A, Arndt V. Trends of incidence, mortality, and survival of multiple myeloma in Switzerland between 1994 and 2013. Cancer Epidemiol. 2018, 53:105-10. 10.1016\/j.canep.2018.01.015","journal-title":"Cancer Epidemiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.0100","article-title":"Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003","volume":"25","author":"Kristinsson SY","year":"2007","unstructured":"Kristinsson SY, Landgren O, Dickman PW, Derolf AR, Bj\u00f6rkholm M. Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003. J Clin Oncol. 2007, 25:1993-9. 10.1200\/JCO.2006.09.0100","journal-title":"J Clin Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01513","article-title":"Prevalence and incidence of multiple myeloma in urban area in China: a national population-based analysis","volume":"9","author":"Wang S","year":"2019","unstructured":"Wang S, Xu L, Feng J, et al.. Prevalence and incidence of multiple myeloma in urban area in China: a national population-based analysis. Front Oncol. 2019, 9:1513. 10.3389\/fonc.2019.01513","journal-title":"Front Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2015.11.007","article-title":"Multiple myeloma: diagnosis and treatment","volume":"91","author":"Rajkumar SV","year":"2016","unstructured":"Rajkumar SV, Kumar S. Multiple myeloma: diagnosis and treatment. Mayo Clin Proc. 2016, 91:101-19. 10.1016\/j.mayocp.2015.11.007","journal-title":"Mayo Clin Proc"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/medsci9010003","article-title":"Epidemiology, staging, and management of multiple myeloma","volume":"9","author":"Padala SA","year":"2021","unstructured":"Padala SA, Barsouk A, Barsouk A, et al.. Epidemiology, staging, and management of multiple myeloma. Med Sci (Basel). 2021, 9:3. 10.3390\/medsci9010003","journal-title":"Med Sci (Basel)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33135","article-title":"Changing trend in mortality rate of multiple myeloma after introduction of novel agents: a population-based study","volume":"147","author":"Usui Y","year":"2020","unstructured":"Usui Y, Ito H, Koyanagi Y, et al.. Changing trend in mortality rate of multiple myeloma after introduction of novel agents: a population-based study. Int J Cancer. 2020, 147:3102-9. 10.1002\/ijc.33135","journal-title":"Int J Cancer"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.4177","article-title":"Patterns of improved survival in patients with multiple myeloma in the twenty-first century: a population-based study","volume":"28","author":"Turesson I","year":"2010","unstructured":"Turesson I, Velez R, Kristinsson SY, Landgren O. Patterns of improved survival in patients with multiple myeloma in the twenty-first century: a population-based study. J Clin Oncol. 2010, 28:830-4. 10.1200\/JCO.2009.25.4177","journal-title":"J Clin Oncol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2005.01.013","article-title":"Renal, hematologic and infectious complications in multiple myeloma","volume":"18","author":"Blad\u00e9 J","year":"2005","unstructured":"Blad\u00e9 J, Rosi\u00f1ol L. Renal, hematologic and infectious complications in multiple myeloma. Best Pract Res Clin Haematol. 2005, 18:635-52. 10.1016\/j.beha.2005.01.013","journal-title":"Best Pract Res Clin Haematol"},{"key":"ref29","article-title":"Immunosuppression and infection in multiple myeloma","volume":"13","author":"Jacobson DR","year":"1986","unstructured":"Jacobson DR, Zolla-Pazner S. Immunosuppression and infection in multiple myeloma. Semin Oncol. 1986, 13:282-90.","journal-title":"Semin Oncol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1086\/605664","article-title":"Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents","volume":"49","author":"Nucci M","year":"2009","unstructured":"Nucci M, Anaissie E. Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents. Clin Infect Dis. 2009, 49:1211-25. 10.1086\/605664","journal-title":"Clin Infect Dis"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0211927","article-title":"Infectious complications and NK cell depletion following daratumumab treatment of multiple myeloma","volume":"14","author":"Nahi H","year":"2019","unstructured":"Nahi H, Chrobok M, Gran C, et al.. Infectious complications and NK cell depletion following daratumumab treatment of multiple myeloma. PLoS One. 2019, 14:e0211927. 10.1371\/journal.pone.0211927","journal-title":"PLoS One"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16235","article-title":"Lenalidomide and the risk of serious infection in patients with multiple myeloma: a systematic review and meta-analysis","volume":"8","author":"Ying L","year":"2017","unstructured":"Ying L, YinHui T, Yunliang Z, Sun H. Lenalidomide and the risk of serious infection in patients with multiple myeloma: a systematic review and meta-analysis. Oncotarget. 2017, 8:46593-600. 10.18632\/oncotarget.16235","journal-title":"Oncotarget"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-553X.2009.01154.x","article-title":"Multiple myeloma presenting with an acute bacterial infection","volume":"31","author":"Kalambokis GN","year":"2009","unstructured":"Kalambokis GN, Christou L, Tsianos EV. Multiple myeloma presenting with an acute bacterial infection. Int J Lab Hematol. 2009, 31:375-83. 10.1111\/j.1751-553X.2009.01154.x","journal-title":"Int J Lab Hematol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0068-5","article-title":"A systematic classification of death causes in multiple myeloma","volume":"8","author":"Mai EK","year":"2018","unstructured":"Mai EK, Haas EM, L\u00fccke S, et al.. A systematic classification of death causes in multiple myeloma. Blood Cancer J. 2018, 8:30. 10.1038\/s41408-018-0068-5","journal-title":"Blood Cancer J"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.77","article-title":"Relevance of age on survival of 341 patients with multiple myeloma treated with conventional chemotherapy: updated results of the MM87 prospective randomized protocol. Cooperative Group of Study and Treatment of Multiple Myeloma","volume":"77","author":"Riccardi A","year":"1998","unstructured":"Riccardi A, Mora O, Brugnatelli S, et al.. Relevance of age on survival of 341 patients with multiple myeloma treated with conventional chemotherapy: updated results of the MM87 prospective randomized protocol. Cooperative Group of Study and Treatment of Multiple Myeloma. Br J Cancer. 1998, 77:485-91. 10.1038\/bjc.1998.77","journal-title":"Br J Cancer"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.01.020","article-title":"Body mass index and risk of multiple myeloma: a meta-analysis of prospective studies","volume":"47","author":"Wallin A","year":"2011","unstructured":"Wallin A, Larsson SC. Body mass index and risk of multiple myeloma: a meta-analysis of prospective studies. Eur J Cancer. 2011, 47:1606-15. 10.1016\/j.ejca.2011.01.020","journal-title":"Eur J Cancer"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/pon.5469","article-title":"Trend of depression and its association with sociodemographic and clinical factors among multiple myeloma hospitalizations: a Portuguese nationwide study from 2000 to 2015","volume":"29","author":"Ribeiro-Carvalho F","year":"2020","unstructured":"Ribeiro-Carvalho F, Gon\u00e7alves-Pinho M, Bergantim R, Freitas A, Fernandes L. Trend of depression and its association with sociodemographic and clinical factors among multiple myeloma hospitalizations: a Portuguese nationwide study from 2000 to 2015. Psychooncology. 2020, 29:1587-94. 10.1002\/pon.5469","journal-title":"Psychooncology"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2013.03.013","article-title":"Validation of the Freiburg Comorbidity Index in 466 multiple myeloma patients and combination with the international staging system are highly predictive for outcome","volume":"13","author":"Kleber M","year":"2013","unstructured":"Kleber M, Ihorst G, Gross B, Koch B, Reinhardt H, W\u00e4sch R, Engelhardt M. Validation of the Freiburg Comorbidity Index in 466 multiple myeloma patients and combination with the international staging system are highly predictive for outcome. Clin Lymphoma Myeloma Leuk. 2013, 13:541-51. 10.1016\/j.clml.2013.03.013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s40487-021-00146-4","article-title":"Real-world treatment patterns and outcomes among multiple myeloma patients with asthma and COPD in the United States","volume":"9","author":"Rice MS","year":"2021","unstructured":"Rice MS, Naeger S, Singh E. Real-world treatment patterns and outcomes among multiple myeloma patients with asthma and COPD in the United States. Oncol Ther. 2021, 9:195-212. 10.1007\/s40487-021-00146-4","journal-title":"Oncol Ther"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2009.07.006","article-title":"Improved survival among younger but not among older patients with multiple myeloma in the Netherlands, a population-based study since 1989","volume":"46","author":"Schaapveld M","year":"2010","unstructured":"Schaapveld M, Visser O, Siesling S, Schaar CG, Zweegman S, Vellenga E. Improved survival among younger but not among older patients with multiple myeloma in the Netherlands, a population-based study since 1989. Eur J Cancer. 2010, 46:160-9. 10.1016\/j.ejca.2009.07.006","journal-title":"Eur J Cancer"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.55.1028","article-title":"Multiple myeloma in the older adult: better prospects, more challenges","volume":"32","author":"Wildes TM","year":"2014","unstructured":"Wildes TM, Rosko A, Tuchman SA. Multiple myeloma in the older adult: better prospects, more challenges. J Clin Oncol. 2014, 32:2531-40. 10.1200\/JCO.2014.55.1028","journal-title":"J Clin Oncol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-298760","article-title":"Racial disparities in incidence and outcome in multiple myeloma: a population-based study","volume":"116","author":"Waxman AJ","year":"2010","unstructured":"Waxman AJ, Mink PJ, Devesa SS, et al.. Racial disparities in incidence and outcome in multiple myeloma: a population-based study. Blood. 2010, 116:5501-6. 10.1182\/blood-2010-07-298760","journal-title":"Blood"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-03-487215","article-title":"Multiethnic myeloma","volume":"121","author":"Weiss BM","year":"2013","unstructured":"Weiss BM. Multiethnic myeloma. Blood. 2013, 121:3062-4. 10.1182\/blood-2013-03-487215","journal-title":"Blood"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1011156","article-title":"Socioeconomic status is independently associated with overall survival in patients with multiple myeloma","volume":"56","author":"Fiala MA","year":"2015","unstructured":"Fiala MA, Finney JD, Liu J, Stockerl-Goldstein KE, Tomasson MH, Vij R, Wildes TM. Socioeconomic status is independently associated with overall survival in patients with multiple myeloma. Leuk Lymphoma. 2015, 56:2643-9. 10.3109\/10428194.2015.1011156","journal-title":"Leuk Lymphoma"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24796","article-title":"Recognition of early mortality in multiple myeloma by a prediction matrix","volume":"92","author":"Terebelo H","year":"2017","unstructured":"Terebelo H, Srinivasan S, Narang M, et al.. Recognition of early mortality in multiple myeloma by a prediction matrix. Am J Hematol. 2017, 92:915-23. 10.1002\/ajh.24796","journal-title":"Am J Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/93329-disparities-in-outcomes-of-hospitalizations-due-to-multiple-myeloma-a-nationwide-comparison","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:07:03Z","timestamp":1707509223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/93329-disparities-in-outcomes-of-hospitalizations-due-to-multiple-myeloma-a-nationwide-comparison"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,19]]},"references-count":45,"URL":"https:\/\/doi.org\/10.7759\/cureus.47319","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,19]]}}}